FDA flags psychiatric risks of asthma drugs
Friday, June 12, 2009 - 16:28
in Health & Medicine
WASHINGTON (AP) -- New labels on popular asthma drugs like Merck's Singulair must highlight language about suicidal behavior, depression and anxiety seen in a small number of patients, federal regulators said Friday....